{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T11:00:28Z","timestamp":1778238028650,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006004","name":"Tohoku University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["15H03015"],"award-info":[{"award-number":["15H03015"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ejpb.2019.01.024","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T01:33:17Z","timestamp":1548552797000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A drug refillable device for transscleral sustained drug delivery to the retina"],"prefix":"10.1016","volume":"136","author":[{"given":"Nobuhiro","family":"Nagai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saaya","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2019.01.024_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2008.10.001","article-title":"Molecular pathology of age-related macular degeneration","volume":"28","author":"Ding","year":"2009","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.ejpb.2019.01.024_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.06.002","article-title":"Molecular pathogenesis of retinal and choroidal vascular diseases","volume":"49","author":"Campochiaro","year":"2015","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.ejpb.2019.01.024_b0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2019.01.024_b0020","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/j.ophtha.2013.05.018","article-title":"A 4-year longitudinal study of 555 patients treated with ranibizumab for neovascular age-related macular degeneration","volume":"120","author":"Rasmussen","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2019.01.024_b0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog. Retin Eye Res."},{"key":"10.1016\/j.ejpb.2019.01.024_b0030","article-title":"Drug delivery devices for retinal diseases","author":"Kaji","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.01.024_b0035","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.biomaterials.2010.11.006","article-title":"A scalable controlled-release device for transscleral drug delivery to the retina","volume":"32","author":"Kawashima","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2019.01.024_b0040","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.actbio.2013.11.004","article-title":"A polymeric device for controlled transscleral multi-drug delivery to the posterior segment of the eye","volume":"10","author":"Nagai","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2019.01.024_b0045","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-319-17121-0_63","article-title":"Transscleral controlled delivery of geranylgeranylaceton using a polymeric device protects rat retina against light injury","volume":"854","author":"Nagai","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1524","key":"10.1016\/j.ejpb.2019.01.024_b0050","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/adhm.201400114","article-title":"A platform for controlled dual-drug delivery to the retina: protective effects against light-induced retinal damage in rats","volume":"3","author":"Nagai","year":"2014","journal-title":"Adv. Healthc Mater."},{"key":"10.1016\/j.ejpb.2019.01.024_b0055","doi-asserted-by":"crossref","first-page":"e58580","DOI":"10.1371\/journal.pone.0058580","article-title":"Transscleral sustained vasohibin-1 delivery by a novel device suppressed experimentally-induced choroidal neovascularization","volume":"8","author":"Onami","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejpb.2019.01.024_b0060","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/jbm.b.33522","article-title":"Protective effects of sustained transscleral unoprostone delivery against retinal degeneration in S334ter rhodopsin mutant rats","volume":"104","author":"Nagai","year":"2016","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ejpb.2019.01.024_b0065","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1167\/iovs.16-20453","article-title":"Long-term protection of genetically ablated rabbit retinal degeneration by sustained transscleral unoprostone delivery","volume":"57","author":"Nagai","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2019.01.024_b0070","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1039\/b804690e","article-title":"A refillable microfabricated drug delivery device for treatment of ocular diseases","volume":"8","author":"Lo","year":"2008","journal-title":"Lab Chip"},{"key":"10.1016\/j.ejpb.2019.01.024_b0075","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10544-009-9313-9","article-title":"A passive MEMS drug delivery pump for treatment of ocular diseases","volume":"11","author":"Lo","year":"2009","journal-title":"Biomed. Microdev."},{"key":"10.1016\/j.ejpb.2019.01.024_b0080","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.visres.2009.10.013","article-title":"The capsule drug device: novel approach for drug delivery to the eye","volume":"50","author":"Molokhia","year":"2010","journal-title":"Vision Res."},{"key":"10.1016\/j.ejpb.2019.01.024_b0085","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3928\/23258160-20181203-01","article-title":"Innovation in neovascular age-related macular degeneration: consideration of brolucizumab abicipar, and the port delivery system","volume":"49","author":"Wykoff","year":"2018","journal-title":"Ophthalmic. Surg. Lasers Imag. Retina"},{"key":"10.1016\/j.ejpb.2019.01.024_b0090","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","article-title":"Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting","volume":"145","author":"Pilli","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2019.01.024_b0095","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1167\/iovs.06-0030","article-title":"Delivery from episcleral exoplants","volume":"47","author":"Pontes de Carvalho","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2019.01.024_b0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1389-1723(04)70240-6","article-title":"Novel biomaterial from reinforced salmon collagen gel prepared by fibril formation and cross-linking","volume":"98","author":"Yunoki","year":"2004","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.ejpb.2019.01.024_b0105","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jbm.b.31121","article-title":"Development of salmon collagen vascular graft: mechanical and biological properties and preliminary implantation study","volume":"87","author":"Nagai","year":"2008","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"10.1016\/j.ejpb.2019.01.024_b0110","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/jbm.a.31110","article-title":"In vitro growth and differentiated activities of human periodontal ligament fibroblasts cultured on salmon collagen gel","volume":"82","author":"Nagai","year":"2007","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2019.01.024_b0115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.addr.2017.12.017","article-title":"Ophthalmic gels: past, present and future","volume":"126","author":"Al-Kinani","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.01.024_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0169-409X(97)00121-X","article-title":"Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery","volume":"31","author":"Ron","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.01.024_b0125","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.addr.2006.09.020","article-title":"Thermo- and pH-responsive polymers in drug delivery","volume":"58","author":"Schmaljohann","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2019.01.024_b0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijpharm.2011.03.042","article-title":"Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release","volume":"411","author":"Rupenthal","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2019.01.024_b0135","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/jbm.a.34106","article-title":"Preparation, characterization, and in vitro enzymatic degradation of chitosan-gelatine hydrogel scaffolds as potential biomaterials","volume":"100","author":"Gorgieva","year":"2012","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2019.01.024_b0140","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1002\/jbm.a.36153","article-title":"Controlled basic fibroblast growth factor release device made of poly(ethyleneglycol) dimethacrylates for creating a subcutaneous neovascular bed for cell transplantation","volume":"105","author":"Yamada","year":"2017","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.ejpb.2019.01.024_b0145","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1167\/iovs.10-6295","article-title":"Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor","volume":"52","author":"Wakusawa","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2019.01.024_b0150","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/IAE.0b013e318233ad0b","article-title":"Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes","volume":"32","author":"Onami","year":"2012","journal-title":"Retina"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118312931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641118312931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:34:13Z","timestamp":1760546053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641118312931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":30,"alternative-id":["S0939641118312931"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.024","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A drug refillable device for transscleral sustained drug delivery to the retina","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2019.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}